The present invention concerns polypeptides comprising a variant Fc region. More particularly, the present invention concerns Fc region-containing polypeptides that have altered effector function as a consequence of one or more amino acid modifications in the Fc region thereof.


< Compounds and methods for modulating cell adhesion

< Secreted and transmembrane polypeptides and nucleic acids encoding the same

> Chemokine alpha-2 antibodies

> Bioactive agent release coating

~ 00295